From HP Enterprise’s notable spike due to AI server sales to Abu Dhabi’s sovereign fund betting big on AI and space tech, this edition of SwissCognitive AI Investment Radar delves into how funds are driving AI innovations across various sectors.


Last Week’s New Investments and Innovations – SwissCognitive AI Investment Radar



Welcome back to our SwissCognitive AI Investment Radar, your premier insight into the universe of AI funds.

From HP’s spike in the stock market fueled by AI server sales to Microsoft UAE’s significant AI investments reshaping the landscape of the Middle East, we’re tracking the pulse of AI across sectors. The fund in AI doesn’t stop at technology giants; it spans diverse fields including healthcare, banking, advertising, and even space tech, underscoring the versatile impact of AI innovations.

This week, we debunk myths surrounding AI in trading, highlighting its potent yet misunderstood capabilities. Simultaneously, we shine a light on startups like Signal and RetinaLogik, who with fresh funding are aim to revolutionize investor decision-making and healthcare respectively.

As the AI domain buzzes with activity—from the large ad/media companies exploring GenAI, through analysts’ shifting focus towards tech giants making AI-centric strides, to sovereign funds like Abu Dhabi’s Mubadala committing to AI and space tech investments—we ponder the strategic considerations companies must weigh before diving deeper into AI.

Thank you for reading this post, don't forget to subscribe to our AI NAVIGATOR!


Join us through of the latest investments news in the AI landscape, providing a clear lens into the potential that lies ahead.

Previous SwissCognitive AI Investments Radar: Steering Through Innovation, Ethics, and Investments.

Our article does not offer financial advice and should not be considered a recommendation to engage in any securities or products. Investments carry the risk of decreasing in value, and investors may potentially lose a portion or all of their investment. Past performance should not be relied upon as an indicator of future results.